Results 321 to 330 of about 487,969 (369)

Surrounding Residential Greenness and Health: Associations With Abdominal Obesity and Dyslipidemia. A Meta-Analysis of Cross-Sectional Studies. [PDF]

Public Health Rev
Marcilla-Toribio I, Bizzozero-Peroni B, Notario-Pacheco B, Cekrezi S, Fernandez-Perez M, Perez-Moreno A, Diez-Fernandez A, Martinez-Andres M.   +7 more
europepmc   +1 more source

Beyond the Milky Pleural Fluid: A 14-Year Study on Non-Traumatic Chylothorax From a Tertiary Care Hospital in India. [PDF]

Cureus
Basha AK, Prakash A, Singh KK, Prajapat D, Talwar D, Talwar D.   +5 more
europepmc   +1 more source

A comparative study on serum lipid levels in patients with thyroid dysfunction: a single-center experience in Ethiopia. [PDF]

BMC Endocr Disord
Kebamo TE, Tantu A, Solomon Y, Walano GA.   +3 more
europepmc   +1 more source

Pharmacokinetics, pharmacogenetics, and toxicity of co-administered efavirenz and isoniazid. [PDF]

South Afr J HIV Med
Taylor J, Maartens G, Sokhela S, Chandiwana N, Akpomiemie G, Venter F, Sinxadi P.   +6 more
europepmc   +1 more source

Association of <i>Helicobacter pylori</i> Infection and Risk of Dyslipidemia: A Systematic Review and Meta-Analysis. [PDF]

JGH Open
Gaonkar A, Zahiruddin QS, Shabil M, Menon SV, Kaur M, Kumari M, Sudan P, Naidu KS, Thapliyal S, Uikey J, Kathuria R, Chauhan SS, Verma L, Sidhu A, Bushi G, Yusoff RBM, Mehta R, Satapathy P, Sah S.   +18 more
europepmc   +1 more source

Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity.

J Clin Endocrinol Metab
Tricò D, Rebelos E, Astiarraga B, Baldi S, Scozzaro T, Sacchetta L, Chiriacò M, Mari A, Ferrannini E, Muscelli E, Natali A.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis

Current Opinion in Endocrinology, Diabetes & Obesity, 2019
Purpose of review In this review, we intend to show the heterogenicity of the triglyceride group, including the triglyceride-rich lipoproteins and its subparticles, apolipoproteins, and its role in atherogenesis through epidemiological and genetic ...
Giuliano Generoso, C. Janovsky, M. Bittencourt   +2 more
semanticscholar   +3 more sources

Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.

European Heart Journal, 2023
AIMS Cholesterol carried in triglyceride-rich lipoproteins, also called remnant cholesterol, is being increasingly acknowledged as an important causal risk factor for atherosclerosis. Elevated remnant cholesterol, marked by elevated plasma triglycerides,
B. Wadström, K. Pedersen, A. Wulff, B. Nordestgaard   +3 more
semanticscholar   +1 more source

Triglycerides and cardiovascular disease

The Lancet, 2014
After the introduction of statins, clinical emphasis first focussed on LDL cholesterol-lowering, then on the potential for raising HDL cholesterol, with less focus on lowering triglycerides. However, the understanding from genetic studies and negative results from randomised trials that low HDL cholesterol might not cause cardiovascular disease as ...
B. Nordestgaard, A. Varbo
semanticscholar   +5 more sources

Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.

European Heart Journal, 2020
AIMS We tested the hypothesis that higher levels of plasma triglycerides and remnant cholesterol are observationally and genetically associated with increased risk of aortic valve stenosis.
M. Kaltoft, A. Langsted, B. Nordestgaard
semanticscholar   +1 more source